Population pharmacokinetics of peginterferon alfa-2b in pediatric patients with chronic hepatitis C

Author： Xu C.   Gupta S.   Krishna G.   Cutler D.   Wirth S.   Galoppo C.   Ciocca M.   Kolz K.   Noviello S.   Sniukiene V.  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.69, Iss.12, 2013-12, pp. : 2045-2054

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C

By Yeh Frank   Gordon Fredric D  

Future Virology, Vol. 2, Iss. 6, 2007-11 ,pp. : 553-563

Future Medicine

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacodynamics of Albinterferon Alfa-2b in Patients Treated for Hepatitis C Virus Genotype 2/3

By  

Anti-Infective Agents, Vol. 12, Iss. 1, 2014-01 ,pp. : 58-67

Bentham Science Publishers

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacodynamics of Albinterferon Alfa-2b in Patients Treated for Hepatitis C Virus Genotype 2/3

By Yu Jing   Sun Haiying   Pang Maria   Chuang Wan-Long   Sarin Shiv K.   Flisiak Robert   Stein Daniel S.  

Anti-Infective Agents, Vol. 12, Iss. 1, 2014-01 ,pp. : 58-67

Bentham Science Publishers

Access to resources Recommend Favorite

PEG-Interferon Alfa-2b for Acute Hepatitis C: A Review

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 8, 2007-08 ,pp. : 839-843

Bentham Science Publishers

Access to resources Recommend Favorite

Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy

By Modi Marlene   Martin Nancy   Heathcote Jenny E   Nieforth Keith   Zeuzem Stefan  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2201-2213

Informa Healthcare

Access to resources Recommend Favorite